| Company | Price | 1D | Market cap | Sector |
|---|---|---|---|---|
| Yuhan Corporation 000100 Yuhan is one of Korea's oldest pharmaceutical companies, selling everyday medicines and consumer health products in its home market. | ₩81,400 | +0.0% | ₩6.0tn | Biopharma |
| Samchundang Pharm 000250 Samchundang Pharm makes prescription medicines in South Korea. | ₩157,000 | +1.0% | ₩3.7tn | Biopharma |
| JW Pharmaceutical 001060 JW Pharmaceutical makes prescription medicines in South Korea. | ₩27,500 | +1.3% | ₩0.6tn | Biopharma |
| Daewoong Co., Ltd. 003090 Daewoong Co., Ltd. | ₩16,860 | -2.0% | ₩1.0tn | Biopharma |
| Boryung Corporation 003850 Boryung Corporation makes prescription medicines in South Korea. | ₩9,040 | +1.6% | ₩0.8tn | Biopharma |
| GC Biopharma Corp. 006280 GC Biopharma Corp. | ₩127,600 | +0.5% | ₩1.5tn | Biopharma |
| Naturecell Co., Ltd. 007390 Naturecell Co., Ltd. | ₩23,950 | +0.2% | ₩1.5tn | Biopharma |
| Hanall Biopharma Co., Ltd. 009420 Hanall Biopharma Co., Ltd. | ₩54,700 | +1.5% | ₩2.9tn | Biopharma |
| Shinpoong Pharmaceutical Co., Ltd. 019170 Shinpoong Pharmaceutical Co., Ltd. | ₩10,010 | -0.9% | ₩0.5tn | Biopharma |
| HLB Co., Ltd. 028300 HLB is a Korean company whose central asset is rivoceranib, a cancer drug it has been pushing toward US approval for liver cancer in combination with a Chinese partner's immunotherapy. | ₩33,750 | +2.9% | ₩4.5tn | Biopharma |
| Oscotec, Inc. 039200 Oscotec, Inc. | ₩36,600 | +1.9% | ₩1.4tn | Biopharma |
| Komipharm International Co., Ltd. 041960 Komipharm International Co., Ltd. | ₩9,710 | +3.5% | ₩0.7tn | Biopharma |
| Celltrion, Inc. 068270 Celltrion is South Korea's largest biosimilar company. | ₩188,100 | +0.5% | ₩43.8tn | Biopharma |
| Celltrion Pharm, Inc. 068760 Celltrion Pharm, Inc. | ₩40,850 | +0.0% | ₩1.8tn | Biopharma |
| Daewoong Pharma 069620 Daewoong Pharma makes prescription medicines in South Korea. | ₩116,100 | +1.1% | ₩1.3tn | Biopharma |
| Chabiotech Co., Ltd. 085660 Chabiotech Co., Ltd. | ₩8,090 | +2.1% | ₩0.8tn | Biopharma |
| Dong Kook Pharmaceutical Co., Ltd. 086450 Dong Kook Pharmaceutical Co., Ltd. | ₩21,600 | -0.9% | ₩1.0tn | Biopharma |
| Medy-Tox, Inc. 086900 Medy-Tox, Inc. | ₩69,600 | +0.4% | ₩0.5tn | Biopharma |
| Peptron, Inc. 087010 Peptron, Inc. | ₩157,300 | +7.3% | ₩3.7tn | Biopharma |
| Qurient Co., Ltd. 115180 Qurient Co., Ltd. | ₩23,050 | +17.3% | ₩0.9tn | Biopharma |
| JS Link 127120 JS Link does research and development in science and engineering in South Korea. | ₩33,600 | +12.4% | ₩1.2tn | Biopharma |
| Hanmi Pharm. Co., Ltd. 128940 Hanmi Pharmaceutical sells prescription drugs in Korea while developing a pipeline in obesity, metabolic disease, and rare conditions, several assets of which it has licensed to Western partners. | ₩473,500 | +2.8% | ₩6.1tn | Biopharma |
| Mezzion Pharma Co., Ltd. 140410 Mezzion Pharma Co., Ltd. | ₩65,000 | +0.0% | ₩2.0tn | Biopharma |
| LigaChem Biosciences Inc. 141080 LigaChem Biosciences develops antibody-drug conjugates, medicines that attach a toxic payload to an antibody so the drug is delivered mainly to tumor cells. | ₩92,000 | +4.2% | ₩3.4tn | Biopharma |
| Hugel, Inc. 145020 Hugel, Inc. | ₩244,000 | +1.5% | ₩3.1tn | Biopharma |
| Chong Kun Dang Pharmaceutical Corp. 185750 Chong Kun Dang Pharmaceutical Corp. | ₩68,000 | -0.3% | ₩0.9tn | Biopharma |
| HK inno.N Corporation 195940 HK inno.N Corporation makes prescription medicines in South Korea. | ₩42,050 | +0.7% | ₩1.2tn | Biopharma |
| Alteogen Inc. 196170 Alteogen is a Korean biotechnology company whose main asset is a platform that converts intravenous antibody drugs into versions a patient can receive as a quick injection under the skin. | ₩288,500 | +1.9% | ₩20.1tn | Biopharma |
| Samsung Biologics Co., Ltd. 207940 Samsung Biologics is the world's largest contract manufacturer of biologic drugs by installed capacity. | ₩1,447,000 | -2.0% | ₩67.0tn | Biopharma |
| Caregen Co., Ltd. 214370 Caregen Co., Ltd. | ₩44,500 | +1.5% | ₩2.4tn | Biopharma |
| Olix Pharmaceuticals, Inc. 226950 Olix Pharmaceuticals, Inc. | ₩95,900 | +4.5% | ₩2.0tn | Biopharma |
| ST Pharm Co., Ltd. 237690 ST Pharm Co., Ltd. | ₩101,200 | +2.2% | ₩2.1tn | Biopharma |
| Ildong Pharm 249420 Ildong Pharm makes prescription medicines in South Korea. | ₩15,030 | -0.5% | ₩0.5tn | Biopharma |
| L & C BIO Co., Ltd. 290650 L & C BIO Co., Ltd. | ₩47,900 | -1.4% | ₩1.3tn | Biopharma |
| ABL Bio Inc. 298380 ABL Bio develops bispecific antibodies and a shuttle technology meant to carry drugs across the blood-brain barrier, the obstacle that has defeated many treatments for brain disease. | ₩71,400 | +5.6% | ₩4.0tn | Biopharma |
| SK Bioscience Co., Ltd. 302440 SK Bioscience Co., Ltd. | ₩37,900 | +0.4% | ₩3.0tn | Biopharma |
| Voronoi, Inc. 310210 Voronoi, Inc. | ₩153,000 | +3.9% | ₩2.8tn | Biopharma |
| Myungin Pharm 317450 Myungin Pharm makes prescription medicines in South Korea. | ₩44,650 | +0.0% | ₩0.7tn | Biopharma |
| SK biopharmaceuticals Co., Ltd. 326030 SK biopharmaceuticals discovered and now sells cenobamate, an epilepsy medicine marketed in the United States as XCOPRI, and it does so through its own American sales force rather than a licensing partner. | ₩86,600 | +0.2% | ₩6.8tn | Biopharma |
| D & D Pharmatech, Inc. 347850 D & D Pharmatech, Inc. | ₩49,200 | +1.4% | ₩2.3tn | Biopharma |
| GI Innovation, Inc. 358570 GI Innovation, Inc. | ₩8,090 | +6.2% | ₩0.5tn | Biopharma |
| April Bio Co., Ltd. 397030 April Bio Co., Ltd. | ₩17,800 | +6.1% | ₩0.5tn | Biopharma |
| G2GBIO, Inc. 456160 G2GBIO, Inc. | ₩37,950 | +5.7% | ₩0.6tn | Biopharma |
| Orum Therapeutics, Inc. 475830 Orum Therapeutics, Inc. | ₩55,900 | +2.6% | ₩1.2tn | Biopharma |
| Onconic Therapeutics, Inc. 476060 Onconic Therapeutics, Inc. | ₩16,440 | -3.9% | ₩0.7tn | Biopharma |
| Rznomics, Inc. 476830 Rznomics, Inc. | ₩28,200 | +6.8% | ₩0.8tn | Biopharma |
| Kolon Tissue Gene, Inc. 950160 Kolon Tissue Gene, Inc. | ₩17,100 | +1.1% | ₩1.5tn | Biopharma |
| Ingenia Therapeutics Inc.(reg.s) 950260 Ingenia Therapeutics Inc.(reg.s) does research and development in science and engineering in South Korea. | ₩15,580 | -1.5% | ₩0.8tn | Biopharma |
| Symbol | Last Price |
|---|---|
| 085660Chabiotech Co., Ltd. | ₩8,090 +2.1% |
| 476060Onconic Therapeutics, Inc. | ₩16,440 -3.9% |
| 041960Komipharm International Co., Ltd. | ₩9,710 +3.5% |
| 317450Myungin Pharm | ₩44,650 +0.0% |
| 001060JW Pharmaceutical | ₩27,500 +1.3% |
| 456160G2GBIO, Inc. | ₩37,950 +5.7% |
| 019170Shinpoong Pharmaceutical Co., Ltd. | ₩10,010 -0.9% |
| 086900Medy-Tox, Inc. | ₩69,600 +0.4% |
| 397030April Bio Co., Ltd. | ₩17,800 +6.1% |
| 249420Ildong Pharm | ₩15,030 -0.5% |